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Background:	 When	 patients’	 kidney	 function	 deteriorates	 to	 Chronic	 Kidney	 Disease	 Stage	 5,	
services	 offer	 patients	 a	 choice	 for	 the	 next	 phase	 of	 their	 care	 –	 conservative	 management	
(diet/fluid/medication)	 or	 renal	 replacement	 therapy	 (dialysis/transplant).	 Dialysis	 may	 not	
have	survival	benefits,	and	conservative	management	may	have	less	treatment	burden,	for	older	














• When	patients	 transition	 from	chronic	kidney	disease	 to	kidney	 failure,	 services	begin	
conversations	 with	 patients	 to	 plan	 for	 the	 next	 treatment	 phase	 offering	 either	 a	
conservative	management	or	a	renal	replacement	pathway	(dialysis	and/or	transplant).	
• There	may	be	no	survival	benefit	of	dialysis	versus	conservative	management	for	certain	
elderly	 patient	 groups,	 and	 the	 burden	 of	 dialysis	 treatment	 means	 conservative	
management	may	be	a	better	option	for	some	patients.	
• Building	 on	 our	 previous	 highly	 successful	 work	 in	 this	 field,	 we	 will	 develop	 the	






evidence	of	 how	 to	help	people	deliberate	 about	 treatment	 information	 in	 accordance	
with	their	personal	circumstances.	
• A	 supporting	 training	 package	 will	 be	 developed	 which	 focusses	 on	 providing	 health	




1. How	 do	 patients	 think	 about	 changes	 in	 their	 disease	 state	 when	 clinical	 markers	
indicate	a	progression	from	kidney	disease	to	kidney	failure?		
2. When	 should	 staff	 begin	 discussions	 about	 the	 conservative	 management/dialysis	
treatment	decision	with	their	patients?	
3. What	do	patients	need	 to	know	about	 their	 illness	and	 treatment	options	 for	 the	next	
phase	of	their	illness	to	make	informed	decisions	about	their	short	and	longer	term	care	
plans?	




	 	 	 	 	
Background	
A	transition	point	for	the	management	of	patients	with	worsening	kidney	disease	occurs	when	






maintain	 some	 functions	 normally	 undertaken	 by	 the	 kidneys).	 When	 renal	 transplant	 is	 not	
medically	appropriate,	dialysis	treatment	(DT)	has	been	offered	as	the	most	clinically	effective	
treatment	option.	The	age	of	patients	receiving	RRT	has	increased	significantly	over	the	last	25	
years	with	 the	 take-on	 rate	of	 those	>65	over	 twice	 the	 take	on	 rate	of	 those	younger	 (Renal	
Registry,	 1998,	 2016),	 meaning	 patients	 starting	 DT	 are	 more	 likely	 to	 have	 co-morbidities,	
increased	 symptom	burden	and	 likelihood	of	 being	 frail	 (Combs	&	Davison,	 2015).	Data	 from	




(Hainsworth,	 2004;	 NICE,	 2008).	 There	 is	 variation	 in	 how	 services	 deliver	 pre-dialysis	
education	 in	 the	 UK,	 and	 how	 CM	 is	 offered	 within	 pre-dialysis	 services	 (Gunda,	 Thomas	 &	
Smith	2005).	Some	frame	CM	as	a	 ‘non-dialysis’	option	(passive)	and/or	as	part	of	a	palliative	






and	 colleagues	 (2015)	 reported	 that	 19.7%	of	 patients	 died	before	 commencing	dialysis	 over	
their	4	year	study	period,	highlighting	the	importance	of	advanced	care	planning	in	this	group.		
Staff	 recognise	 a	 need	 for	 more	 training	 and	 resources	 to	 help	 them	 discuss	 CM	 as	 an	 active	
option	with	patients	(Bristowe	et	al	2014,	Fortnum	et	al	2015).	They	report	a	need	for	balanced	
information	on	the	benefits	and	risks	of	both	CM	and	dialysis,	impact	on	patients’	quality	of	life,	
carer	 burden,	 and	 end	 of	 life	 care	 planning	 (Noble	 et	 al	 2009).	 Patients	 with	 ESKD	 report	
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wanting	 more	 guidance	 in	 making	 treatment	 decisions	 (Hussain	 et	 al,	 2015),	 and	 at	 earlier	
phases	 in	 their	 care	 pathway	 (Wright	 Nunes	 et	 al,	 2016),	 yet	 doctors	 feel	 unprepared	 for	
discussing	end	of	life	issues	with	patients	(Schell	&	Cohen,	2014;	Schell	et	al,	2012).	To	support	




Patient	 Decision	 Aids	 (PtDAs)	 are	 resources	 that	 support	 people	 to	 make	 more	 informed	
decisions	between	treatment	options	than	those	receiving	usual	care	(Bekker	et	al,1999,	2015;	
Bekker,	 2010,	 Winterbottom	 et	 al,	 2016).	 PtDAs	 are	 evidence-based,	 drawing	 on	 decision	
science	 studies	 to	 identify	 components	 that	 boost,	 or	 bias,	 people’s	 thinking	 (Bekker,	 2013;	
2010;	 Volk	 et	 al,	 2013).	 We	 established	 that	 patients	 represent	 the	 ‘dialysis	 decision’	 as	 a	
hierarchy	 of	 nested	 choices,	 i.e.	 first	 the	 dialysis	 versus	 ‘no	 dialysis’	 decision,	 and	 second	 the	
‘between	dialysis	modalities’	decision	(see	Figure	1;	Winterbottom	et	al,	2014).	We	developed	
The	Dialysis	Decision	Aid	Booklet	(Bekker	et	al,	2015)	to	support	people	with	worsening	kidney	
disease	 make	 informed	 decisions	 between	 the	 second	 of	 these	 choices	 -	 the	 choice	 between	
dialysis	modalities	(Winterbottom	et	al,	2016).	It	was	not	designed	to	help	people	think	about	
whether	or	not	to	have	dialysis,	although	this	decision	was	signposted.	The	reasons	people	give	
in	 retrospect	 for	 deciding	 between	 CM	 and	 dialysis	 are	 varied	 and	 include	 patient	 lifestyle,	
treatment	 preferences,	 healthcare	 and	 end	 of	 life	 perceptions;	 communication	 and	 service	
delivery	 (Morton	 et	 al,	 2012).	 People	 identify	 attributes	 important	 to	 them	 for	 their	 decision,	
and	 they	 trade-off	 what	 is	 important	 to	 them.	 However	 it	 is	 unclear	 how	 to	 present	 this	
information	 neutrally	 and	 in	 a	 way	 that	 supports	 people	 to	 reason	 proactively	 between	 the	
‘dialysis	treatment’	and	‘CM’	options,	before	making	a	choice.	Several	patient	resources	present	
CM	 as	 an	 option	 for	 comparison	 alongside	 three	 renal	 replacement	 options	 (haemodialysis,	












attend	 steering	 group	 meetings	 and	 provide	 input/feedback	 throughout	 the	 project	 as	
appropriate	e.g.	reviewing	patient	information	sheets/protocol	submission/interview	schedules.	
The	study	 is	awaiting	Health	Research	Authority,	under	 review	by	 the	Yorkshire	and	Humber	









• Establish	 the	 clinical	 context	 and	 challenges	 to	 developing	 the	 PtDA	 using	 interviews	
and	observational	methods	(Phase	2).	





• Develop	 a	 staff	 training	 package	 to	 support	 health	 professionals	 use	 of	 the	 PtDA	 and	





to	developing,	 evaluating	and	 implementing	 complex	 interventions	 (Medical	Research	Council	












for	DT/CM	choice.	A	coding	 frame	will	be	developed	with	reference	 to	 renal	policy	guidelines	
and	checklists	of	content,	style	and	formatting	known	to	be	associated	with	written	information	
quality	 and	 decision-making	 facilitation.	 These	 materials	 will	 be	 adapted	 from	 our	 work	
surveying	dialysis	information	(Winterbottom	et	al,	2007).		










We	 will	 critically	 evaluate	 the	 strengths	 and	 weaknesses	 of	 decision	 support	 interventions	
designed	for	this	decision	context.		
Sample	 -	 PtDAs	 published	 internationally	 comparing	 treatment	 options	 for	 patients	 with	
CKD/ESKD.	
Materials	 –	 Data	 extraction	 form	 developed	 for	 purpose	 and	 informed	 by	 our	 past	 work	 in	
dialysis	 decision	 making	 and	 PtDA	 research	 (Bekker	 et	 al,	 1999,	 2013;	 Winterbottom	 et	 al.,	
2007;	Sepucha	et	al.,	2017),	including	IPDASv4	checklist	for	assessing	PtDA	quality	(Volk	et	al,	
2013).	
Data	 collection	 –	 PtDAs	 will	 be	 selected	 from	 literature	 searches	 and	 contact	 with	 leading	
researchers	 in	 the	 field.	 For	 each	 PtDA	 key	 characteristics	 (e.g.	 treatment	 options	 described,	
description	 of	 health	 issue)	 will	 be	 identified	 and	 extracted	 systematically	 using	 the	 data	
extraction	 form.	 Two	 judgments-of-resource-quality	 grids	 will	 be	 applied:	 IPDAS	 criteria	 grid	












effectiveness	 of	 CM/DT	 (NICE,	 2008),	 service	 frameworks;	 existing	 patient	 information;	
patient/professional	surveys	of	CM/DT	choices	(e.g.	Morton	et	al,	2010;	van	Biesen	et	al,	2014;	
Caskey	2016);	 behavioural	 decision	 support	 guidance	 and	 frameworks	 for	PtDA	development	







who	have	 switched	 treatments;	 and	 staff	who	oversee	 and	manage	 the	 care	 of	 these	 patients	
will	 be	 invited	 to	 take	 part.	 Exclusion	 criteria:	 adults	 unable	 to	 speak	 English	 and/or	 those	
lacking	 cognitive	 capacity	 to	 take	 part	 in	 an	 interview.	 Participants	 will	 be	 recruited	 and	
consented	at	outpatient	clinics	at	 the	Adult	Renal	Unit,	St	 James	University	Hospital,	Leeds	by	
research	nurses/project	manager.		
Study	materials	 -	Study	 information	 sheets,	 consent	 forms	 to	 inform	and	 recruit	 participants	
and	an	interview	guide	for	staff	and	patients	are	developed.		
Data	collection	–	from	two	sources:		
a) Semi-structured	 interviews	with	staff,	patient	and	carers	will	 elicit	 views	 about	 how	 to	
make	 sense	 of	 CKD	 and	 changes	 to	 management	 over	 time	 using	 current	 PtDAs	 as	
prompts.	 Staff	 will	 be	 interviewed	 about	 how	 they	 support	 patient’s	 decisions	 with	
transitions	 in	 CKD	 between	 different	 treatment	 pathways	 (CM/DT/withdrawal)	 and	
discuss	 training	needs.	 Interviews	will	be	conducted	by	project	manager	(AW),	 last	no	




b) Audio-recorded	 consultations	 between	 health	 professionals	 and	 patients	 will	 explore	
current	 practice	 in	 terms	 of	 how	 options	 are	 introduced	 and	 discussed	 and	 further	
identify	training	needs.	Consultations	last	approximately	20-30	minutes.	
Data	analysis	 -	 Interviews	 and	 observations	will	 be	 tape	 recorded,	 transcribed	 and	 analysed	






all	 decision	 options	 and	 their	 consequences	 in	 accordance	 with	 their	 values,	 to	 help	 patients	
made	trade-offs	about	treatments	 in	discussion	with	kidney	professionals	(Bekker	et	al,	1999;	





clarification	 tasks	 (Stigglebout,	 2000)	 will	 help	 patients	 unpack	 the	 choices	 in	 this	
decision.	 Technical	 details	 will	 be	 packaged	 within	 phrases	 that	 help	 patients	 make	
sense	of	the	treatments	within	their	representation	of	kidney	disease	(Timmers,	2008).		









implement	decisions	made	 in	 consultation	with	patients	across	hospital	 systems	and	 in	 inter-
professional	 communication.	 We	 will	 draw	 on	 current	 training	 guidelines/existing	 training	





the	 studies	 and	 to	 recruit	 them	 to	 take	 part	 have	 been	 developed.	 The	 PtDA	 and	 training	
package	will	be	included	for	use.	
Data	collection	–	Data	will	be	collected	from	two	sources:	
a) Focus	 groups	 with	 staff	 to	 provide	 feedback	 on	 resource	 development	 and	 identify	
changes	 in	 system	 factors	 to	 ensure	 the	 resource	 can	 be	 integrated	 into	 existing	
operating	procedures	to	allow	inter-professional	communication	across	services.	












approach	 through	 the	 development	 a	 theory	 driven,	 evidence-based	 resource.	 It	 should	 also	
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increase	 patient	 uptake	 of	 the	 most	 appropriate	 treatment	 option	 allowing	 efficient	 resource	
allocation	and	 lead	 to	patients	 receiving	appropriate	management	 for	 their	ESKD	by	enabling	
patient	 preferences	 to	 be	 integrated	 into	 care	 planning.	 Whilst	 this	 research	will	 not	 provide	
evidence	of	the	PtDAs	effectiveness	on	healthcare	outcomes	our	findings	will	provide	evidence	
to	inform	the	study	design	for	evaluating	the	effectiveness	of	this	complex	intervention	and	this	
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